These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52. The role of augmentation therapy in alpha-1 antitrypsin deficiency. Kueppers F Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542 [TBL] [Abstract][Full Text] [Related]
53. Replacement therapy for hereditary alpha1-antitrypsin deficiency. A program for long-term administration. Barker AF; Siemsen F; Pasley D; D'Silva R; Buist AS Chest; 1994 May; 105(5):1406-10. PubMed ID: 8181327 [TBL] [Abstract][Full Text] [Related]
54. Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies. Ferrarotti I; Corsico AG; Stolk J; Ottaviani S; Fumagalli M; Janciauskiene S; Iadarola P COPD; 2017 Feb; 14(1):56-65. PubMed ID: 27827549 [TBL] [Abstract][Full Text] [Related]
55. Pulmonary Emphysema in a Child With Alpha-1 Antitrypsin Deficiency: Evaluation of 2 Years of Intravenous Augmentation Therapy. Esteves Brandão M; Conde B; Seixas S; Clotilde Silva J; Fernandes A Arch Bronconeumol (Engl Ed); 2019 Sep; 55(9):502-504. PubMed ID: 30871819 [No Abstract] [Full Text] [Related]
56. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update. Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067 [TBL] [Abstract][Full Text] [Related]
57. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615 [TBL] [Abstract][Full Text] [Related]